GO:1902047 polyamine transmembrane transport

Polyamines are small, polycationic macromolecules that are required for fundamental cellular processes such as nucleic acid stabilization, translation and stress adaptation. Because they cannot freely diffuse across lipid bilayers in a controlled manner, cells rely on dedicated transport systems to move them across membranes. GO:1902047, polyamine transmembrane transport, is the Gene Ontology biological process that captures this membrane-crossing step, and it is annotated with the synonyms polyamine import and polyamine uptake. The term is deliberately broad: it covers transport across the plasma membrane as well as across organellar membranes, and it applies to prokaryotic, fungal, plant and animal systems. For researchers, GO:1902047 is a useful organizing concept because polyamine transport sits at the intersection of metabolism, membrane biology and disease. In bacteria and yeast, polyamine transport determines how cells acquire exogenous polyamines and how they respond to osmotic and oxidative stress. In plants, the same process underlies the uptake of paraquat, a herbicide that competes with polyamines for transport, which provided one of the earliest genetic handles on plant polyamine transporters. In humans, defects in polyamine transport machinery are associated with neurodegeneration, and structural work on ATP13A2 (PARK9) has revealed how a human P5B-ATPase recognizes and translocates polyamines. More recently, the structure and mechanism of a human vesicular polyamine transporter have been resolved, extending the term to organellar transport. This article summarizes the authoritative GO definition, the mechanistic stages of polyamine transmembrane transport, the genes and proteins involved, and the experimental methods, including CRISPR-based models, that are used to study it. All statements are grounded in the verified literature cited by number.

According to the QuickGO definition, GO:1902047 (polyamine transmembrane transport) is the process in which a polyamine macromolecule is transported across a membrane. The term is a biological process and carries the synonyms polyamine import and polyamine uptake. In practice, this means the directed movement of a polyamine substrate from one side of a lipid bilayer to the other, mediated by a protein transporter rather than by unregulated diffusion. The definition does not restrict the membrane type, so it covers plasma membrane uptake and export as well as transport across organellar membranes, and it applies across taxa from bacteria and yeast to plants and humans.

Polyamine transmembrane transport is important because it sets the intracellular concentration of polyamines, which in turn influences growth, stress resistance and survival. When transport is disrupted, cells can neither acquire enough polyamines from the environment nor maintain appropriate organellar pools, and the consequences range from impaired stress responses in microbes and plants to neurodegeneration in humans. Because transport is a membrane-delimited and genetically encodable step, it is also a tractable target for functional genomics and for therapeutic hypothesis testing.

The following genes and proteins have been directly implicated in polyamine transmembrane transport or in its structural and mechanistic characterization.

Polyamine transmembrane transport is regulated at multiple levels. In bacteria and yeast, transport activity responds to the availability of exogenous polyamines and to cellular energy status, allowing cells to balance uptake with biosynthesis and catabolism. In plants, the transport pathway is shared with paraquat, so substrate competition and environmental exposure influence net transport rates. In humans, the activity of ATP13A2 and of the vesicular polyamine transporter is tied to membrane trafficking and to the structural states of the transporter proteins, which provides additional regulatory layers. Because these mechanisms are conserved in outline but divergent in detail, comparative studies across taxa remain important for defining regulatory logic.

ATP13A2 (PARK9) is a human P5B-ATPase that transports polyamines, and its structural characterization has provided a mechanistic basis for understanding how loss of transport function could contribute to neurodegeneration. Because ATP13A2 is a membrane transporter, disease-associated changes in its activity are expected to alter polyamine distribution across membranes, which is consistent with the broader link between polyamine transport and neuronal survival.

The human vesicular polyamine transporter moves polyamines across organellar membranes, and its structure and mechanism have been resolved. This places polyamine transmembrane transport within the biology of vesicular trafficking, where altered transport could affect organellar polyamine pools and downstream cellular functions.

In plants, polyamine transporters were identified through their ability to transport paraquat, a herbicide that competes with polyamines. This link means that polyamine transmembrane transport is directly relevant to herbicide uptake, oxidative stress and plant stress physiology, and it provides a genetically defined entry point for crop and weed biology studies.

In bacteria and yeast, polyamine transport systems determine how cells acquire polyamines from the environment and how they cope with stress. Because these systems are conserved in outline, they serve as tractable models for understanding how transport contributes to survival under adverse conditions.

Direct transport assays measure the movement of labeled or unlabeled polyamines across membranes. These assays have been central to characterizing bacterial, yeast and plant polyamine transport systems, and they remain the primary way to confirm that a candidate gene product mediates polyamine transmembrane transport.

Cryo-electron microscopy and crystallography have been used to determine the structures of human ATP13A2 and of the human vesicular polyamine transporter, providing mechanistic insight into substrate recognition and conformational cycling. These methods are essential for linking sequence variants to transport function.

Genetic screens in yeast and plants identified polyamine transport genes and linked them to paraquat uptake. In mammalian systems, CRISPR-based screens extend this approach by testing candidate transporters and modifiers at scale.

RNA-seq, proteomics and imaging are used to determine where polyamine transporters are expressed and which membranes they localize to. These approaches complement transport assays and structural work by placing transporters in their cellular context.

Researchers studying polyamine transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in moving polyamines across a membrane, or whether it merely correlates with transport activity. Answering that question requires clean genetic models in which the candidate gene is deleted, mutated, tagged or overexpressed, followed by functional transport assays. EDITGENE provides these models as an integrated service so that transport hypotheses can be tested directly in the cell type of interest.

GO:1902047 polyamine transmembrane transport defines the membrane-crossing step that controls polyamine availability inside cells and organelles. The process is conserved across bacteria, yeast, plants and humans, and it is mediated by dedicated transporters such as ATP13A2 (PARK9) and the human vesicular polyamine transporter. Because transport is genetically encodable and membrane-delimited, it is an attractive target for functional genomics and for disease-oriented research. Testing whether a specific gene mediates polyamine transmembrane transport requires clean genetic models and quantitative transport assays. CRISPR knockout, point-mutation, knock-in and overexpression approaches provide the causal evidence needed to move from correlation to mechanism, and they can be paired with structural and screening methods to build a complete picture of polyamine transport biology.